Natixis Advisors, L.P. Care Dx, Inc. Transaction History

Natixis Advisors, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$28.19 - $46.6 $300,449 - $496,662	-10,658 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$41.2 - $73.6 $439,109 - $784,428	10,658 New	10,658 $485,000
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $651,064 - $1.01 Million	-11,007 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$63.02 - $95.11 $693,661 - $1.05 Million	11,007 New	11,007 $1.01 Million

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.